Product
Fimasartan + Indapamide
1 clinical trial
1 indication
Indication
HypertensionClinical trial
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy in Comparison With Fimasartan Monotherapy for Essential Hypertension Patients Not Adequately Responded by Fimasartan 30 mgStatus: Recruiting, Estimated PCD: 2024-10-01